Bronnen:
Kärppä M, Ning X, Galic M, et al, Reduction in the number of headache hours and days with fremanezumab in patients with migraine and documented inadequate response to 2-4 migraine preventive medications in the international, multicentre, randomised, placebo-controlled FOCUS study. 5th European Academy of Neurology (EAN) Congress, abstract EPO3096.
Kärppä M, Ning X, Galic M, et al, Reduction in the number of headache hours and days with fremanezumab in patients with migraine and documented inadequate response to 2-4 migraine preventive medications in the international, multicentre, randomised, placebo-controlled FOCUS study. 5th European Academy of Neurology (EAN) Congress, abstract EPO3096.